Tag: manufacturing defects

Addressing Texture Non-Uniformity in Ointments Post Bulk Hold: An Investigation Framework Texture non-uniformity in ointments and creams can lead to product complaints, tension during quality reviews, and increased regulatory scrutiny.…

Understanding and Investigating Viscosity Drift During Homogenization Viscosity drift during the homogenization process can lead to substantial manufacturing defects in ointments and creams. Such deviations can result in out-of-specification (OOS)…

Understanding and Addressing Texture Non-Uniformity During Transfer in Pharmaceutical Manufacturing Texture non-uniformity during transfer poses significant challenges in the pharmaceutical manufacturing of ointments and creams. This defect can affect product…

Understanding and Addressing pH Variations During Transfer: A Comprehensive Investigation In pharmaceutical manufacturing, maintaining control over product quality is crucial. One such quality parameter, pH stability, is often compromised during…

Understanding Microbial Contamination During Transfer: An Investigation Framework Microbial contamination during transfer processes poses a significant threat to pharmaceutical manufacturing quality and compliance. Such incidents can result in out-of-specification (OOS)…

Addressing Phase Separation Issues During Transfer: A Comprehensive Investigation Guide Phase separation in ointments and creams during transfer can signify serious manufacturing defects that may compromise product integrity and patient…

Investigating Phase Separation Issues Following Packaging Changes Phase separation in ointments and creams can lead to significant manufacturing defects, notably after changes in packaging. This article equips pharmaceutical professionals with…